Scholarlink

<p>Ultrasound neurostimulation (USNS) offers non-invasive access to deep mood-regulating circuits, but most protocols rely on arbitrary parameters and lack mechanistic evaluation. We first optimised single-pulse USNS in healthy mice by mapping pressure–response curves during motor cortex stimulation with behavioural scoring, electromyography and hydrophone measurements to define a focal, reproducible setting. We then applied repeated USNS to the infralimbic cortex, the rodent homologue of ventromedial prefrontal cortex, for five days during unpredictable chronic mild stress. Behavioural outcomes (nest-building, open-field exploration), whole-brain <sup>18</sup>F-FDG microPET and targeted metabolomics in infralimbic cortex, amygdala and hippocampus were assessed. Optimised infralimbic USNS selectively activated local neurons, reversed self-care and anxiety-like deficits to near baseline and outperformed chronic fluoxetine. PET revealed sustained hypermetabolism in vmPFC, dorsal hippocampus, periaqueductal grey and raphe nuclei, while metabolomics showed coordinated down-regulation of glutamate-centred pathways, supporting USNS as a precise, non-destructive antidepressant-like intervention.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Optimized ultrasound neurostimulation of ventromedial prefrontal cortex reverses depression behaviours and normalizes brain metabolism

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月18日

查看全文
  • Marc Legrand,
  • Laurent Galineau,
  • Anthony Novell,
  • Barbara Planchez,
  • Bruno Brizard,
  • Samuel Leman,
  • Clovis Tauber,
  • Jean-Michel Escoffre,
  • Sophie Serriere,
  • Tarik Iazourene,
  • Wissam El-Hage,
  • Patrick Emond,
  • Catherine Belzung,
  • Ayache Bouakaz

摘要

Ultrasound neurostimulation (USNS) offers non-invasive access to deep mood-regulating circuits, but most protocols rely on arbitrary parameters and lack mechanistic evaluation. We first optimised single-pulse USNS in healthy mice by mapping pressure–response curves during motor cortex stimulation with behavioural scoring, electromyography and hydrophone measurements to define a focal, reproducible setting. We then applied repeated USNS to the infralimbic cortex, the rodent homologue of ventromedial prefrontal cortex, for five days during unpredictable chronic mild stress. Behavioural outcomes (nest-building, open-field exploration), whole-brain 18F-FDG microPET and targeted metabolomics in infralimbic cortex, amygdala and hippocampus were assessed. Optimised infralimbic USNS selectively activated local neurons, reversed self-care and anxiety-like deficits to near baseline and outperformed chronic fluoxetine. PET revealed sustained hypermetabolism in vmPFC, dorsal hippocampus, periaqueductal grey and raphe nuclei, while metabolomics showed coordinated down-regulation of glutamate-centred pathways, supporting USNS as a precise, non-destructive antidepressant-like intervention.